biotech · Coronary Artery Disease · Bronchopulmonary Dysplasia · ASBP
Aspire Biopharma Holdings
Aspire Biopharma Holdings patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Humacao, USA HQ
2019 Founded
Public company Type
ASBP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Humacao, USA
- Founded
- 2019
- Programs
- 8
- Drugs
- 8
- Patents
- 1
Aspire Biopharma Holdings patents
1 pharmaceutical patents indexed for Aspire Biopharma Holdings. 0 expire within 24 months.
Aspire Biopharma Holdings has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Aspire Biopharma Holdings have?
1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Aspire Biopharma Holdings patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.